Market intelligence
ASNDSector not reported
Ascendis Pharma A/S - ADR insider activity
In the last 90 days, 2 corporate insiders purchased $681,946 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 1
- 90-day purchase value
- $777,067
- Corporate buyers
- 2
- Latest transaction
- Aug 14, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
